Literature DB >> 17955446

Genetic predisposition to self-curing infection with the protozoan Leishmania chagasi: a genomewide scan.

Selma M B Jeronimo1, Priya Duggal, Nicholas A Ettinger, Eliana T Nascimento, Gloria R Monteiro, Angela P Cabral, Nubia N Pontes, Henio G Lacerda, Paula V Queiroz, Carlos E M Gomes, Richard D Pearson, Jenefer M Blackwell, Terri H Beaty, Mary E Wilson.   

Abstract

The protozoan Leishmania chagasi can cause disseminated, fatal visceral leishmaniasis (VL) or asymptomatic infection in humans. We hypothesized that host genetic factors contribute to this variable response to infection. A family study was performed in neighborhoods of endemicity for L. chagasi near Natal in northeastern Brazil. Study subjects were assessed for the presence of VL or asymptomatic infection, which was defined by a positive delayed-type hypersensitivity (DTH) skin test response to Leishmania antigen without disease symptoms. A genomewide panel of 385 autosomal microsatellite markers in 1254 subjects from 191 families was analyzed to identify regions of linkage. Regions with potential linkage to the DTH response on chromosomes 15 and 19, as well as a novel region on chromosome 9 with potential linkage to VL, were identified. Understanding the genetic factors that determine whether an individual will develop symptomatic or asymptomatic infection with L. chagasi may identify proteins essential for immune protection against this parasitic disease and reveal strategies for immunotherapy or prevention.

Entities:  

Mesh:

Year:  2007        PMID: 17955446      PMCID: PMC2330094          DOI: 10.1086/521682

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  [Evaluation of the sensitization power of Montenegro skin test].

Authors:  F F José; I M da Silva; M I Araújo; R P Almeida; O Bacellar; E M Carvalho
Journal:  Rev Soc Bras Med Trop       Date:  2001 Nov-Dec       Impact factor: 1.581

2.  Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.

Authors:  Gonçalo R Abecasis; Stacey S Cherny; William O Cookson; Lon R Cardon
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

3.  Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection.

Authors:  Theresa M Karplus; Selma M B Jeronimo; Haeok Chang; Bethany K Helms; Trudy L Burns; Jeffrey C Murray; Adele A Mitchell; Elizabeth W Pugh; Regina F S Braz; Fabiana L Bezerra; Mary E Wilson
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  The sensitivity and specificity of Leishmania chagasi recombinant K39 antigen in the diagnosis of American visceral leishmaniasis and in differentiating active from subclinical infection.

Authors:  Regina F S Braz; Eliana T Nascimento; Daniella R A Martins; Mary E Wilson; Richard D Pearson; Steven G Reed; Selma M B Jeronimo
Journal:  Am J Trop Med Hyg       Date:  2002-10       Impact factor: 2.345

5.  Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1.

Authors:  H S Mohamed; M E Ibrahim; E N Miller; C S Peacock; E A G Khalil; H J Cordell; J M M Howson; A M El Hassan; R E H Bereir; J M Blackwell
Journal:  Genes Immun       Date:  2003-07       Impact factor: 2.676

6.  A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar.

Authors:  Bruno Bucheton; Laurent Abel; Sayda El-Safi; Musa M Kheir; Sylvana Pavek; Arnaud Lemainque; Alain J Dessein
Journal:  Am J Hum Genet       Date:  2003-10-13       Impact factor: 11.025

7.  Selection of a skin test antigen for American visceral leishmaniasis.

Authors:  S G Reed; R Badaró; H Masur; E M Carvalho; R Lorenco; A Lisboa; R Teixeira; W D Johnson; T C Jones
Journal:  Am J Trop Med Hyg       Date:  1986-01       Impact factor: 2.345

Review 8.  Heterogeneity of the Y chromosome in Afro-Brazilian populations.

Authors:  Kiyoko Abe-Sandes; Wilson A Silva; Marco A Zago
Journal:  Hum Biol       Date:  2004-02       Impact factor: 0.553

9.  An emerging peri-urban pattern of infection with Leishmania chagasi, the protozoan causing visceral leishmaniasis in northeast Brazil.

Authors:  Selma M B Jeronimo; Priya Duggal; Regina F S Braz; Chun Cheng; Gloria R G Monteiro; Eliana T Nascimento; Daniella R A Martins; Theresa M Karplus; Maria F F M Ximenes; Carlos C G Oliveira; Vanessa G Pinheiro; Wogelsanger Pereira; Jose M Peralta; Jacira Sousa; Iara M Medeiros; Richard D Pearsoni; Trudy L Burns; Elizabeth W Pugh; Mary E Wilson
Journal:  Scand J Infect Dis       Date:  2004

10.  The burden of Leishmania chagasi infection during an urban outbreak of visceral leishmaniasis in Brazil.

Authors:  G L Werneck; L Rodrigues; M V Santos; I B Araújo; L S Moura; S S Lima; R B B Gomes; J H Maguire; C H N Costa
Journal:  Acta Trop       Date:  2002-07       Impact factor: 3.112

View more
  27 in total

1.  Genome-Wide Association Study of Cell-Mediated Response in Dogs Naturally Infected by Leishmania infantum.

Authors:  Luís F S Batista; Yuri T Utsunomiya; Thaís B F Silva; Raíssa A Dias; Thaise Y Tomokane; Acácio D Pacheco; Vânia L R da Matta; Fernando T Silveira; Mary Marcondes; Cáris M Nunes; Márcia D Laurenti
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

2.  Cytokine responses to novel antigens in a peri-urban population in Brazil exposed to Leishmania infantum chagasi.

Authors:  Carmel B Stober; Selma M B Jeronimo; Nubia N Pontes; E Nancy Miller; Jenefer M Blackwell
Journal:  Am J Trop Med Hyg       Date:  2012-07-23       Impact factor: 2.345

3.  Fine mapping under linkage peaks for symptomatic or asymptomatic outcomes of Leishmania infantum infection in Brazil.

Authors:  Jason L Weirather; Priya Duggal; Eliana L Nascimento; Gloria R Monteiro; Daniella R Martins; Henio G Lacerda; Michaela Fakiola; Jenefer M Blackwell; Selma M B Jeronimo; Mary E Wilson
Journal:  Infect Genet Evol       Date:  2016-05-04       Impact factor: 3.342

4.  CD45RO+ T Cells and T Cell Activation in the Long-Lasting Immunity after Leishmania infantum Infection.

Authors:  João F Rodrigues-Neto; Gloria R Monteiro; Tatjana S L Keesen; Henio G Lacerda; Edgar M Carvalho; Selma M B Jeronimo
Journal:  Am J Trop Med Hyg       Date:  2017-12-21       Impact factor: 2.345

5.  Structures of Leishmania major orthologues of macrophage migration inhibitory factor.

Authors:  Julia M Richardson; Lesley S Morrison; Nicholas D Bland; Sandra Bruce; Graham H Coombs; Jeremy C Mottram; Malcolm D Walkinshaw
Journal:  Biochem Biophys Res Commun       Date:  2009-01-31       Impact factor: 3.575

6.  TGF-beta and mesenchymal hepatic involvement after visceral leishmaniasis.

Authors:  Maria Irma Seixas Duarte; Heitor Franco de Andrade; Cleusa Fumica Hirata Takamura; Antonio Sesso; Felipe Francisco Tuon
Journal:  Parasitol Res       Date:  2008-12-05       Impact factor: 2.289

Review 7.  Genetics and visceral leishmaniasis: of mice and man.

Authors:  J M Blackwell; M Fakiola; M E Ibrahim; S E Jamieson; S B Jeronimo; E N Miller; A Mishra; H S Mohamed; C S Peacock; M Raju; S Sundar; M E Wilson
Journal:  Parasite Immunol       Date:  2009-05       Impact factor: 2.280

8.  Genetic admixture in Brazilians exposed to infection with Leishmania chagasi.

Authors:  Nicholas A Ettinger; Priya Duggal; Regina F S Braz; Eliana T Nascimento; Terri H Beaty; Selma M B Jeronimo; Richard D Pearson; Jenefer M Blackwell; Lina Moreno; Mary E Wilson
Journal:  Ann Hum Genet       Date:  2009-03-27       Impact factor: 1.670

Review 9.  Control of visceral leishmaniasis in latin america-a systematic review.

Authors:  Gustavo A S Romero; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2010-01-19

10.  Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis.

Authors:  Aurelie Cobat; Caroline J Gallant; Leah Simkin; Gillian F Black; Kim Stanley; Jane Hughes; T Mark Doherty; Willem A Hanekom; Brian Eley; Jean-Philippe Jaïs; Anne Boland-Auge; Paul van Helden; Jean-Laurent Casanova; Laurent Abel; Eileen G Hoal; Erwin Schurr; Alexandre Alcaïs
Journal:  J Exp Med       Date:  2009-11-09       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.